Rory McCulloch

9PUBLICATIONS
38CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 21, 2023
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Ann Tivey, Rohan Shotton, Toby A Eyre

|May 15, 2023
Post-BTK inhibitor mantle cell lymphoma: When is CAR-T not the answer?

Rory McCulloch

|Feb 23, 2021
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.

Rory McCulloch, David Lewis, Nicola Crosbie

|Feb 04, 2020
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy.

Rory McCulloch, Carlo Visco, Toby A Eyre

Pageof 2